Search

Yang Chia-Chi Cao

from Suwanee, GA
Age ~42
Get Report
Also known as:
Yang Caoko
Related to:
Xinmin Cao, 76Junsheng Cao, 47Michelle Chae, 54Richard Jennings, 96Kathie J Lee, 49
Connected to:
Alain A Cao, 39Alex T Cao, 51Alexandra H Cao, 35Anne M Cao, 49Annie N Cao, 50Ben T Cao, 55Cam D Cao, 70Carol A Cao, 45Chen Cao, 51Chieu X Cao, 61

Yang Cao Phones & Addresses

  • Suwanee, GA
  • 217 River Pine Dr, Morrisville, NC 27560
  • 101 Swiftwater Ct, Cary, NC 27513 (551) 226-9264
  • Montville, NJ
  • Little Ferry, NJ
  • 514 Hamilton St, Harrison, NJ 07029 (973) 481-2976
  • East Newark, NJ
  • Los Angeles, CA
  • Ithaca, NY
  • 101 Swiftwater Ct, Cary, NC 27513

Work

Company: Tang & Associates PC Address: 3901 Main St Ste 203, Flushing, NY 11354

Education

School / High School: Cornell Law School

Ranks

Licence: New York - Currently registered Date: 2011

Professional Records

Lawyers & Attorneys

Yang Cao Photo 1

Yang Cao, Flushing NY - Lawyer

View page
Address:
Tang & Associates PC
3901 Main St Ste 203, Flushing, NY 11354
(718) 762-5300 (Office)
Licenses:
New York - Currently registered 2011
Education:
Cornell Law School

License Records

Yang Cao

License #:
19921 - Active
Issued Date:
Oct 21, 1999
Expiration Date:
Jun 30, 2017
Type:
Certified Public Accountant

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yang Cao
Secretary
SUNFLOWER CREATIONS, INCORPORATED
1070 Blackwood Ct, Suwanee, GA 30024
Yang Cao
Software Developer
AMERICHOICE OF NEW YORK, INC
Health/Allied Services Accident/Health Insurance Carrier · Hospital/Medical Service Plan Accident/Health Insurance Carrier · Health/Allied Services · Insurance Companies
7 Hanover Sq 5 Flr, New York, NY 10004
7 Hanover Sq, New York, NY 10004
(212) 509-5999, (212) 898-8400, (212) 509-1458, (212) 509-1929
Yang Cao
ADONAMEIDA, INC
Nonclassifiable Establishments
28-08 141 St #4E, Flushing, NY 11354
2808 141 St, Flushing, NY 11354

Publications

Us Patents

Methods For Determining The Potency, Specificity, And Toxicity Of Microsomal Prostaglandin E2 Synthase

View page
US Patent:
7132256, Nov 7, 2006
Filed:
Jun 24, 2005
Appl. No.:
11/165779
Inventors:
Yang Cao - Bridgewater NJ, US
Stephen Ayers - Logan Township NJ, US
Jeffrey Sabol - Bridgewater NJ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
C12Q 1/02
US Classification:
435 29
Abstract:
Methods of determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase inhibitors are provided that utilize one cell-based assay system.

Methods For Determining The Potency, Specificity, And Toxicity Of Hematopoietic Prostaglandin D2 Synthase

View page
US Patent:
20070259384, Nov 8, 2007
Filed:
Jul 28, 2005
Appl. No.:
11/569146
Inventors:
Yang Cao - Bridgewater NJ, US
Jeffrey Sabol - Bridgewater NJ, US
Stephen Ayers - Monmouth Junction NJ, US
Assignee:
AVENTIS PHARMACEUTICALS INC. - Bridgewater NJ
International Classification:
G01N 33/53
US Classification:
435007210
Abstract:
The present invention relates to a novel and useful method for assaying compounds and agents for their ability to decrease or inhibit the activity of hematopoietic prostaglandin D2 synthase (hPGDS). Specifically, the present invention relates to assays for measuring the potency, specificity and toxicity of hPGDS inhibitors.

Mucarinic Agonists And Methods Of Use Thereof

View page
US Patent:
20090012101, Jan 8, 2009
Filed:
Dec 8, 2006
Appl. No.:
12/159426
Inventors:
Yang Cao - Scotch Plains NJ, US
Frederick Tejada - Toledo OH, US
Assignee:
UNIVERSITY OF TOLEDO - Toledo OH
International Classification:
A61K 31/439
C07D 453/02
A61K 31/506
A61P 25/18
C07D 401/14
US Classification:
514256, 546133, 546112, 544333, 514305, 514299
Abstract:
A method of forming analogs of CDD-0304, i.e., tetra(ethyleneglycol) (4-methoxy-1,2,5-thiadiazol-3-yl)[3-(1-methyl-1,2,4,5-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl]ether hydrochloride includes one or more of the following steps: a) replacing the tetrahydropyridine moiety with one of the following heterocyclic rings, including quinuclidine, [2.2.1]-exo-azabicy-cloheptane, [2.2.1]-endo-azabicycloheptane and terahydropyrimidine; b) varying the length of the linking group by replacing the tetra(ethylene) glycol moiety with one of: ethylene glycol, di(ethylene) glycol, penta(ethylene) glycol, or diether diol; and/or, c) replacing the 1,2,5-thiadiazole moiety with an ester isostere. Also, a method for an asymmetric analog CCD-0304 includes replacing at least one moiety with an ester isostere and at least a second moiety with an ammonium isostere. Also, such analogs compounds and their uses are disclosed.

Modulation Of Complement System Activation For Treatment Of Bleeding-Related Inflammation

View page
US Patent:
20100092493, Apr 15, 2010
Filed:
Mar 6, 2008
Appl. No.:
12/529980
Inventors:
Yang Cao - North Brunswick NJ, US
Assignee:
NOVO NORDISK A/S - Bagsvaerd
International Classification:
A61K 39/395
A61K 38/36
A61K 38/37
A61K 38/48
A61P 29/00
US Classification:
4241751, 424 945, 424 9464
Abstract:
This invention provides, inter alia, methods and compositions for treating, reducing the incidence of, reducing the severity of, or delaying onset or advancement, of synovitis and/or bleeding-associated inflammation in a subject in need thereof. The compositions comprise, and methods make use of, an effective amount of an agent, which abrogates or diminishes activation of the C5aR complement pathway in said subject, and optionally other therapeutic agents including a coagulation factor, other hemostatic factor, and/or second anti-inflammatory agent.

Ring Puzzle Games

View page
US Patent:
20230079345, Mar 16, 2023
Filed:
Aug 29, 2022
Appl. No.:
17/898266
Inventors:
Yang CAO - EAST MEADOW NY, US
International Classification:
A63F 9/08
Abstract:
Novel ring puzzles containing a plurality of rings supported on at least one elongated loop are provided, where at least one ring of the plurality of rings is connected to more than one adjacent ring in its front, at least one of the plurality of the rings has a diameter different than that of the other of the plurality of rings, or the elongated loop includes at least two elongated loops arranged in parallel.

Processes For The Preparation Of Sugammadex

View page
US Patent:
20210206884, Jul 8, 2021
Filed:
Jun 3, 2019
Appl. No.:
17/059925
Inventors:
- Rahway NJ, US
Nadine Kuhl - Garwood NJ, US
Wenyong Chen - Princeton NJ, US
Yang Cao - Scotch Plains NJ, US
Alan Michael Hyde - Metuchen NJ, US
Susan L. Zultanski - Brooklyn NY, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C08B 37/16
Abstract:
The present invention provides processes for the preparation of sugammadex: (I) In one aspect, there is provided a process for the preparation of sugammadex from 8-per-deoxy-8-bromo-γ-cyclodextrin and 3-mercaptopropionic acid. In another aspect, there is provided an alternative process for the preparation of sugammadex from 8-per-deoxy-8-bromo-γ-cyclodextrin and disodium 3-mercaptopropionate. In another aspect, there is provided a process for the preparation of 8-per-deoxy-8-bromo-γ-cyclodextrin, which may be used in the production of sugammadex. In one such aspect, there is provided a process for the preparation of 8-per-deoxy-8-bromo-γ-cyclodextrin from γ-cyclodextrin and a brominating agent. In another such aspect, there is provided a process for the preparation of 8-per-deoxy-8-bromo-γ-cyclodextrin comprising, inter alia, reacting γ-cyclodextrin with an electrophilic brominating agent, a deoxygenating agent, and an acid in the presence of an organic solvent.

Space Maze Puzzle With Reconfigurable Paths

View page
US Patent:
20200054937, Feb 20, 2020
Filed:
Aug 19, 2019
Appl. No.:
16/544306
Inventors:
Yang CAO - EAST MEADOW NY, US
International Classification:
A63F 7/04
A63F 7/30
Abstract:
A space puzzle including a plurality of outer face panels, at least two of the plurality of outer face panels each defining at least one path segment. Each of the outer face panels is rotatable, and the rotation of any one of the outer face panels is independent of and not altering any path segment defined in another of the outer face panels. The path segments on the at least two of the outer face panels of the puzzle are configured such that at least one sequence of rotations of at least one of the at least two of the outer face panels exists that permits a position indicator to travel along a continuous pathway between a preset starting point and a preset finish point along the at least one path segment of the at least two of the plurality of outer face panels.

Process For Preparing Chiral Dipeptidyl Peptidase-Iv Inhibitors

View page
US Patent:
20180093992, Apr 5, 2018
Filed:
Dec 5, 2017
Appl. No.:
15/831895
Inventors:
- Rahway NJ, US
Feng Peng - Edison NJ, US
Yonggang Chen - Westfield NJ, US
Amude Mahmoud Kassim - Fairless Hills PA, US
Cheng-yi Chen - Princeton NJ, US
Mathew Maust - Manville NJ, US
Mark McLaughlin - Summit NJ, US
Michael J. Zacuto - Jersey City NJ, US
Qinghao Chen - Edison NJ, US
Lushi Tan - Edison NJ, US
Zhiguo Jake Song - Edison NJ, US
Yang Cao - Scotch Plains NJ, US
Feng Xu - Staten Island NY, US
International Classification:
C07D 487/04
A61K 31/4162
Abstract:
A process for preparing a compound of structural Formula Ia:
Control profile
Yang Chia-Chi Cao from Suwanee, GA, age ~42 Get Report